Ketoanalogues in Elderly Patients with Chronic Kidney Disease

Guideline-Based Recommendations

The KDIGO guidelines recommend considering a very low-protein diet (0.3-0.4 g/kg body weight/day) supplemented with essential amino acids or ketoacid analogs (up to 0.6 g/kg body weight/day) under close supervision for adults with CKD at risk of kidney failure who are willing and able 1
The KDIGO guidelines emphasize avoiding low or very low-protein diets only in metabolically unstable patients 1
The American Geriatrics Society recommends considering higher protein and calorie dietary targets for older adults with underlying conditions such as frailty and sarcopenia 1

Check renal function (serum creatinine, eGFR) at baseline and within 2-4 weeks after initiation, then every 3 months 2
Monitor serum calcium and phosphorus at least every 3 months, as ketoanalogues improve bone mineral metabolism parameters 2
Assess nutritional status including serum albumin, prealbumin, and hemoglobin every 3 months 2
Screen for metabolic acidosis (serum bicarbonate) at least every 3 months, though ketoanalogues tend to improve bicarbonate levels 2

Do not prescribe ketoanalogues to metabolically unstable elderly patients (those with acute illness, severe malnutrition, or recent hospitalization) 1
Avoid in elderly patients with severe frailty or sarcopenia without first optimizing their protein and calorie intake to the higher end of normal ranges 1
Do not use ketoanalogues as monotherapy—they must be combined with appropriate protein restriction and close dietary supervision, preferably with a renal dietitian 1
Never assume normal renal function based on serum creatinine alone in elderly patients—always calculate eGFR using appropriate equations 3

Be cautious of polypharmacy interactions: Elderly CKD patients often take multiple medications that require renal dose adjustment 4
Avoid concurrent use of medications that worsen renal function: NSAIDs, certain antibiotics, and contrast agents should be avoided or used with extreme caution 4
Severe renal impairment (CrCl <30 mL/min) when considering other renally-cleared medications alongside ketoanalogues 3 5